IP Library Granted Patent US 7,214,487
Granted Patent B2
US 7,214,487 · App. 10/374,499 · Granted May 8, 2007

Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates

Assignee: Sunesis Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,214,487
App. No.
10/374,499
Granted
May 8, 2007
Kind
B2
Abstract

The present invention relates to methods for identifying compounds that modulate enzymatic activity by contacting covalently bonded PTP-extender complexes or modified covalently bonded PTP-extender complexes with ligand candidates.

Claims (33)

1. A method for identifying a candidate ligand comprising:

a) providing a PTP (protein tyrosine phosphatase) having a reactive thiol located outside of its active site;

b) contacting the PTP with an extender thereby forming a PTP-extender complex wherein the extender comprises a first functionality that forms a covalent bond with the reactive thiol and a second functionality that is capable of forming a disulfide bond;

c) contacting the PTP-extender complex with a candidate ligand that comprises a group that is capable of forming a disulfide bond with the second functionality;

d) forming a disulfide bond between the PTP-extender complex and the candidate ligand thereby forming a PTP-extender-ligand conjugate; and,

e) identifying the candidate ligand present in the PTP-extender-ligand conjugate.

2. The method of claim 1 wherein the reactive thiol on PTP is a naturally occurring -SH from a cysteine that is part of the naturally occurring protein sequence.

3. The method of claim 1 wherein the reactive thiol on the PTP is from a cysteine where mutagenesis was used to replace a naturally occurring amino acid.

4. The method of claim 1 wherein the reactive thiol is masked as a disulfide.

5. The method of claim 1 wherein the covalent bond between the reactive thiol and the first functionality is an irreversible covalent bond.

6. The method of claim 1 wherein the covalent bond between the reactive thiol and the first functionality is a reversible covalent bond.

7. The method of claim 1 wherein the PTP-extender complex is contacted with a candidate ligand in the presence of a reducing agent.

8. The method of claim 7 wherein the reducing agent is selected from the group consisting of: cysteine, cysteamine, dithiothreitol, dithioerythritol, glutathione, 2-mercaptoethanol, 3-mercaptoproprionic acid, a phosphine such as tris-(2-carboxyethylphosphine), and sodium borohydride.

9. The method of claim 1 wherein the extender is selected from the group consisting of

10. A method of identifying a candidate ligand comprising:

a) providing a PTP (protein tyrosine phosphatase) having an active site, a cysteine located in its active site and a reactive thiol located outside of the active site;

b) contacting the PTP with an extender thereby forming a PTP-extender complex, the extender comprising a first functionality and a latent second functionality, a cleavable linker and a binding determinant comprising a phosphotyrosine or a phosphotyrosine mimetic wherein the first functionality forms a first covalent bond with the reactive thiol and the binding determinant binds to the active site;

c) cleaving the extender at the cleavable linker thereby forming a modified PTP-extender complex thereby exposing the second functionality and releasing the binding determinant from the active site;

d) contacting the modified PTP-extender complex with a candidate ligand that comprises a group that is capable of forming a second covalent bond with the second functionality;

e) forming a second covalent bond between the modified PTP-extender complex and the candidate ligand thereby forming a PTP-extender-ligand conjugate; and,

f) identifying the candidate ligand present in the PTP-extender-ligand conjugate.

11. The method of claim 10 wherein the reactive thiol on PTP is a naturally occurring —SH from a cysteine that is part of the naturally occurring protein sequence.

12. The method of claim 10 wherein the reactive thiol on the PTP is from a cysteine where mutagenesis was used to replace a naturally occurring amino acid.

13. The method of claim 10 wherein the reactive thiol is masked as a disulfide.

14. The method of claim 10 wherein the covalent bond between the reactive thiol and the first functionality is an irreversible covalent bond.

15. The method of claim 10 wherein the covalent bond between the reactive thiol and the first functionality is a reversible covalent bond.

16. The method of claim 10 wherein PTP-extender complex is contacted with a candidate ligand in the presence of a reducing agent.

17. The method of claim 16 wherein the reducing agent is selected from the group consisting of: cysteine, cysteamine, dithiothreitol, dithioerythritol, glutathione, 2-mercaptoethanol, 3-mercaptoproprionic acid, a phosphine such as tris-(2-carboxyethylphosphine), and sodium borohydride.

18. The method of claim 10 wherein the extender is of the formula

where A is selected from the group consisting of:

n is 1–5; m is 2–5; and, X is a halide.

19. The method of claim 18 wherein A is selected from the group consisting of:

n and m are independently 2 or 3; and X is bromide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2003
From: ERLANSON, DANIEL A.; MCDOWELL, ROBERT S.; HANSEN, STIG
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 013794/0443 →
Continuity (7)
Continuation In Part 1012121600 · Apr 10, 2002
Continuation In Part 0998154700 · Oct 17, 2001
Division 0910537200 · Jun 26, 1998
Continuation In Part 0999042100 · Nov 21, 2001
Provisional Application 6037703400 · May 1, 2002
Provisional Application 6025229400 · Nov 21, 2000
Related Publication 20040005632A1 · Jan 8, 2004